These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 19336372)

  • 1. Cytokines associated with bronchopulmonary dysplasia or death in extremely low birth weight infants.
    Ambalavanan N; Carlo WA; D'Angio CT; McDonald SA; Das A; Schendel D; Thorsen P; Higgins RD;
    Pediatrics; 2009 Apr; 123(4):1132-41. PubMed ID: 19336372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum cytokine concentrations, chorioamnionitis and the onset of bronchopulmonary dysplasia in premature infants.
    Kaneko M; Sato M; Ogasawara K; Imamura T; Hashimoto K; Momoi N; Hosoya M
    J Neonatal Perinatal Med; 2017; 10(2):147-155. PubMed ID: 28409755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of postnatal corticosteroid use on neurodevelopment at 18 to 22 months' adjusted age: effects of dose, timing, and risk of bronchopulmonary dysplasia in extremely low birth weight infants.
    Wilson-Costello D; Walsh MC; Langer JC; Guillet R; Laptook AR; Stoll BJ; Shankaran S; Finer NN; Van Meurs KP; Engle WA; Das A;
    Pediatrics; 2009 Mar; 123(3):e430-7. PubMed ID: 19204058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum eotaxin-1 is increased in extremely-low-birth-weight infants with bronchopulmonary dysplasia or death.
    Kandasamy J; Roane C; Szalai A; Ambalavanan N
    Pediatr Res; 2015 Nov; 78(5):498-504. PubMed ID: 26270578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood cytokines during the perinatal period in very preterm infants: relationship of inflammatory response and bronchopulmonary dysplasia.
    Paananen R; Husa AK; Vuolteenaho R; Herva R; Kaukola T; Hallman M
    J Pediatr; 2009 Jan; 154(1):39-43.e3. PubMed ID: 18760808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes and significance of type 2 innate lymphoid cells and their related factors in bronchopulmonary dysplasia].
    Wang QW; Zhu Y; Wang QX; Lu HY
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 Feb; 25(2):179-185. PubMed ID: 36854695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of extremely low birth weight (<1 kg) and extremely low gestational age (<28 weeks) infants with bronchopulmonary dysplasia: effects of practice changes in 2000 to 2003.
    Kobaly K; Schluchter M; Minich N; Friedman H; Taylor HG; Wilson-Costello D; Hack M
    Pediatrics; 2008 Jan; 121(1):73-81. PubMed ID: 18166559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in survival among extremely-low-birth-weight infants (less than 1000 g) without significant bronchopulmonary dysplasia.
    Botet F; Figueras-Aloy J; Miracle-Echegoyen X; Rodríguez-Miguélez JM; Salvia-Roiges MD; Carbonell-Estrany X
    BMC Pediatr; 2012 Jun; 12():63. PubMed ID: 22682000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood Cytokine Profiles Associated with Distinct Patterns of Bronchopulmonary Dysplasia among Extremely Low Birth Weight Infants.
    D'Angio CT; Ambalavanan N; Carlo WA; McDonald SA; Skogstrand K; Hougaard DM; Shankaran S; Goldberg RN; Ehrenkranz RA; Tyson JE; Stoll BJ; Das A; Higgins RD;
    J Pediatr; 2016 Jul; 174():45-51.e5. PubMed ID: 27117196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia.
    Yoon BH; Romero R; Jun JK; Park KH; Park JD; Ghezzi F; Kim BI
    Am J Obstet Gynecol; 1997 Oct; 177(4):825-30. PubMed ID: 9369827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants.
    Laughon MM; Langer JC; Bose CL; Smith PB; Ambalavanan N; Kennedy KA; Stoll BJ; Buchter S; Laptook AR; Ehrenkranz RA; Cotten CM; Wilson-Costello DE; Shankaran S; Van Meurs KP; Davis AS; Gantz MG; Finer NN; Yoder BA; Faix RG; Carlo WA; Schibler KR; Newman NS; Rich W; Das A; Higgins RD; Walsh MC;
    Am J Respir Crit Care Med; 2011 Jun; 183(12):1715-22. PubMed ID: 21471086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between fluid intake and weight loss during the first ten days of life and risk of bronchopulmonary dysplasia in extremely low birth weight infants.
    Oh W; Poindexter BB; Perritt R; Lemons JA; Bauer CR; Ehrenkranz RA; Stoll BJ; Poole K; Wright LL;
    J Pediatr; 2005 Dec; 147(6):786-90. PubMed ID: 16356432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical characteristics and risk factors of very low birth weight and extremely low birth weight infants with bronchopulmonary dysplasia: multicenter retrospective analysis].
    Jiangsu Multicenter Study Collaborative Group for Breastmilk Feeding in Neonatal Intensive Care Units
    Zhonghua Er Ke Za Zhi; 2019 Jan; 57(1):33-39. PubMed ID: 30630229
    [No Abstract]   [Full Text] [Related]  

  • 14. Intercenter differences in bronchopulmonary dysplasia or death among very low birth weight infants.
    Ambalavanan N; Walsh M; Bobashev G; Das A; Levine B; Carlo WA; Higgins RD;
    Pediatrics; 2011 Jan; 127(1):e106-16. PubMed ID: 21149431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preterm cord blood CD4⁺ T cells exhibit increased IL-6 production in chorioamnionitis and decreased CD4⁺ T cells in bronchopulmonary dysplasia.
    Misra R; Shah S; Fowell D; Wang H; Scheible K; Misra S; Huyck H; Wyman C; Ryan RM; Reynolds AM; Mariani T; Katzman PJ; Pryhuber GS
    Hum Immunol; 2015 May; 76(5):329-338. PubMed ID: 25797206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of serum and bronchoalveolar fluid lavage pro- and anti-inflammatory cytokine levels for predicting bronchopulmonary dysplasia in premature infants.
    Köksal N; Kayik B; Çetinkaya M; Özkan H; Budak F; Kiliç Ş; Canitez Y; Oral B
    Eur Cytokine Netw; 2012 Jun; 23(2):29-35. PubMed ID: 22591771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
    Doyle LW; Cheong JL; Ehrenkranz RA; Halliday HL
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD001145. PubMed ID: 29063594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth and neurodevelopmental outcomes after early low-dose hydrocortisone treatment in extremely low birth weight infants.
    Watterberg KL; Shaffer ML; Mishefske MJ; Leach CL; Mammel MC; Couser RJ; Abbasi S; Cole CH; Aucott SW; Thilo EH; Rozycki HJ; Lacy CB
    Pediatrics; 2007 Jul; 120(1):40-8. PubMed ID: 17606560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The airway microbiome of intubated premature infants: characteristics and changes that predict the development of bronchopulmonary dysplasia.
    Lohmann P; Luna RA; Hollister EB; Devaraj S; Mistretta TA; Welty SE; Versalovic J
    Pediatr Res; 2014 Sep; 76(3):294-301. PubMed ID: 24941215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory activity at school age in very low birth weight bronchopulmonary dysplasia survivors.
    Korhonen PH; Suursalmi PH; Kopeli T; Nieminen R; Lehtimäki L; Luukkaala T; Korppi M; Saari A; Moilanen E; Tammela OK
    Pediatr Pulmonol; 2015 Jul; 50(7):683-90. PubMed ID: 24668942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.